Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (2315.HK)
HKSE - HKSE Delayed price. Currency in HKD
Add to watchlist
At close: 04:08PM HKT
| Previous close | 7.400 |
| Open | 7.400 |
| Bid | 7.510 x N/A |
| Ask | 7.650 x N/A |
| Day's range | 7.370 - 7.870 |
| 52-week range | 5.740 - 21.500 |
| Volume | |
| Avg. volume | 132,737 |
| Market cap | 3.055B |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- PR Newswire
Biocytogen Awarded U.S. Patent for RenLite® Common Light Chain Mouse Platform
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. ("Biocytogen", HKEX: 02315) announced United States Patent and Trademark Office (USPTO) patent grant for independently developed RenLite® fully human common light chain mouse platform.
© 2024 Yahoo. All rights reserved.